A Study of Nivolumab in Selected Uterine Cancer Patients

Clinical trial NCT03241745 · COMPLETED

Trial details

NCT number: NCT03241745
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Uterine Cancer Endometrial Carcinoma Carcinosarcoma Leiomyosarcoma Undifferentiated Sarcoma High Grade Endometrial Stromal Sarcoma Clear Cell Carcinoma

Start date: 2017-08-03
Primary completion: 2024-04-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.